480 filings
Page 13 of 24
SC 13G/A
ACST
Acasti Pharma Inc.
13 Feb 19
Acasti Pharma Inc.
12:00am
6-K
ACST
Acasti Pharma Inc.
8 Feb 19
Acasti Pharma Schedules Third Quarter Fiscal 2019 Conference Call
8:05am
6-K
ACST
Acasti Pharma Inc.
9 Jan 19
Acasti Pharma Awarded Broad Composition-of-Matter and Method of Use Patents by the European Patent Office
8:05am
6-K
ACST
Acasti Pharma Inc.
31 Dec 18
Current report (foreign)
8:00am
6-K
ACST
Acasti Pharma Inc.
20 Dec 18
Acasti Pharma Achieves Planned Enrollment Targets for TRILOGY Phase 3 Trials of CaPreĀ® in Patients with Severe Hypertriglyceridemia
8:01am
6-K
ACST
Acasti Pharma Inc.
14 Nov 18
Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019
8:05am
6-K
ACST
Acasti Pharma Inc.
14 Nov 18
Current report (foreign)
7:00am
6-K
ACST
Acasti Pharma Inc.
7 Nov 18
Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call
8:01am
6-K
ACST
Acasti Pharma Inc.
23 Oct 18
Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering of Common Shares Including the Exercise of the Over-Allotment Option
9:21am
EFFECT
ACST
Acasti Pharma Inc.
18 Oct 18
Notice of effectiveness
12:15am
6-K
ACST
Acasti Pharma Inc.
15 Oct 18
Current report (foreign)
5:15pm
POS AM
ACST
Acasti Pharma Inc.
12 Oct 18
Prospectus update (post-effective amendment)
5:05pm
CORRESP
ACST
Acasti Pharma Inc.
12 Oct 18
Correspondence with SEC
12:00am
6-K
ACST
Acasti Pharma Inc.
11 Oct 18
Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares
7:42am
6-K
ACST
Acasti Pharma Inc.
9 Oct 18
Current report (foreign)
5:21pm
424B5
ACST
Acasti Pharma Inc.
5 Oct 18
Prospectus supplement for primary offering
12:00am
6-K
ACST
Acasti Pharma Inc.
4 Oct 18
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
11:00am
6-K
ACST
Acasti Pharma Inc.
4 Oct 18
Acasti Pharma Prices C$24 Million Underwritten Offering
11:00am
6-K
ACST
Acasti Pharma Inc.
3 Oct 18
Acasti Pharma Announces Proposed Underwritten Public Offering of Common Shares
5:15pm
6-K
ACST
Acasti Pharma Inc.
3 Oct 18
Acasti Pharma Announces Public Equity Offering
5:15pm